T. Rowe Price Health Care ETF (TMED)
| Assets | $14.74M |
| Expense Ratio | 0.44% |
| PE Ratio | 26.54 |
| Shares Out | 500,000 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Ratio | n/a |
| 1-Year Return | n/a |
| Volume | 12,007 |
| Open | 29.79 |
| Previous Close | 29.76 |
| Day's Range | 29.64 - 29.79 |
| 52-Week Low | 23.46 |
| 52-Week High | 30.54 |
| Beta | n/a |
| Holdings | 103 |
| Inception Date | Jun 11, 2025 |
About TMED
Fund Home PageThe T. Rowe Price Health Care ETF (TMED) is an exchange-traded fund. The ETF currently has 16.04m in AUM and 95 holdings. TMED is an actively managed ETF, aiming to outperform its respective sector index TMED was launched on Jun 11, 2025 and is issued by T. Rowe Price.
Top 10 Holdings
50.64% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 14.70% |
| UnitedHealth Group Incorporated | UNH | 7.23% |
| Abbott Laboratories | ABT | 4.65% |
| Intuitive Surgical, Inc. | ISRG | 3.83% |
| AbbVie Inc. | ABBV | 3.80% |
| Thermo Fisher Scientific Inc. | TMO | 3.77% |
| Gilead Sciences, Inc. | GILD | 3.72% |
| Danaher Corporation | DHR | 3.29% |
| State Street U.S. Government Money Market Portfolio | GVMXX | 2.96% |
| Cytokinetics, Incorporated | CYTK | 2.69% |
News
Active Healthcare ETF TMED Sending Buy Signal
Active ETFs continue to rise in significance for investors, with flows on track for another record amid more and more launches. Amid that rise for the category, certain ETFs have stood out of late, th...
T. Rowe Price Expands ETF Lineup With 3 Actively Managed Sector Picks Across Key Sectors
In a world where passive investing tends to dominate the headlines, T. Rowe Price is gambling on an alternative formula: sector-focused active management, and at lower costs.
T. ROWE PRICE ADDS THREE NEW TRANSPARENT SECTOR OFFERINGS TO ITS ACTIVE ETF ROSTER
BALTIMORE, June 12, 2025 /PRNewswire/ -- T. Rowe Price (NASDAQ-GS: TROW), a global investment management firm, announced today the addition of three new active transparent equity exchange-traded funds...